TY - JOUR T1 - Management of Painful Bone Metastases: Our Experience According to Scientific Evidence on Palliative Radiotherapy JF - Anticancer Research JO - Anticancer Res SP - 1011 LP - 1014 VL - 34 IS - 2 AU - ROSSELLA DI FRANCO AU - SARA FALIVENE AU - VINCENZO RAVO AU - MASSIMO MAMMUCARI AU - ENNIO SARLI AU - STELLA BAFFINI AU - GIAMPAOLO DE PALMA AU - ALFONSINA PEPE AU - MARIANNA TRAETTINO AU - MATTEO MUTO AU - SALVATORE CAPPABIANCA AU - PAOLO MUTO Y1 - 2014/02/01 UR - http://ar.iiarjournals.org/content/34/2/1011.abstract N2 - Aim: Our aim was to evaluate retrospectively the role of the radiotherapy in the multi-disciplinary management of pain due to bone metastases. Patients and Methods: A total of 305 patients received radiotherapy with or without bisphosphonate and antalgic drugs. Tolerability and efficacy were evaluated using a Numerical Rating Scale, Pain Intensity Difference evaluation scale related to administration of the drug, a 5-point verbal scale of the patients' general impression. Results: We found differences in some patient subgroups: pain reduction was significantly more evident in patients treated with a single-fraction radiotherapy scheme. Overall, 68% of patients experienced an improvement in pain control using concomitant drugs during radiotherapy. Conclusion: Our study underlines the role of radiotherapy in the management of metastatic bone pain. The use of rapid-onset opioids to prevent predictable pain is a crucial step in managing radiotherapy. An interdisciplinary approach is recommended. ER -